Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01621295 · ClinicalTrials.gov registry record

Assessing the Patient Experience in Cancer Care

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
408
Enrollment target

NCT01621295: Completed study, sponsored by Mayo Clinic.

NCT01621295 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 408 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01621295 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
408 participants
Enrollment target

Study Summary

Communication is an important component of comprehensive cancer care impacting patient satisfaction, adherence, and quality of life. The wide array of issues addressed in cancer clinical interactions makes communicating about a broad range of topics (including quality of life, communication, symptom control, complementary/alternative therapies, costs, treatment burden, prognosis, anxiety, side-effects, sexual function, palliative care options, etc.) especially interesting and potentially challenging. Some of these topics may not be routinely addressed in the clinical interaction or may require consultative support from other members of the comprehensive cancer care team. One frequently overlooked critical element in research on communication between cancer clinicians, their patients, and their primary care clinicians is describing real-time consultations between patients and their clinicians. These interactions provide rich material for assessing key psycho-social dynamics and identifying issues that patients find important in their care. In order to devise systems of care that optimize the patient experience, it is critical that clinicians and researchers understand, appreciate, and systematically characterize the richness and complexity of the decision-making process in routine cancer consultations between cancer patients and their treating clinicians. This study seeks to assess the patient experience in cancer care by observing patients and their physicians in their clinical interactions and following them for several months to see how their care went. By describing in-depth the conversations and experiences of patients in these clinical interactions, this study will lay the foundation for practice-based interventions to optimize patients' interactions with their cancer care teams.

Trial Details

FieldValue
Enrollment Target 408 participants
Start Date 2012-05
Est. Completion 2015-09

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT01621295

The ClinicalTrials.gov registry entry for NCT01621295 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 408 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01621295 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01621295 about?

NCT01621295 is a clinical study titled "Assessing the Patient Experience in Cancer Care". Communication is an important component of comprehensive cancer care impacting patient satisfaction, adherence, and quality of life. The wide array of issues addressed in cancer clinical interactions makes communicating about a broad range of topics (including quality of life, communication, symptom...

What is the current status of trial NCT01621295?

This trial is currently completed. The enrollment target is 408 participants. The study started on 2012-05. Estimated completion is 2015-09.

Who is sponsoring clinical trial NCT01621295?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.